RAYDERM RE-GENERATING SERUM (GLYCERIN SERUM) LOTION [VORY MEDICAL. INC]

RAYDERM RE-GENERATING SERUM (GLYCERIN SERUM) LOTION [VORY MEDICAL. INC]
PDF | XML

NDC 72543-003-01
Set ID f3202ee6-c191-4506-9a94-c3de6aed82c1
Category HUMAN OTC DRUG LABEL
Packager VORY MEDICAL. Inc
Generic Name
Product Class
Product Number
Application Number
  • ACTIVE INGREDIENT

    Glycerin (9.703%) - Skin Protectact

  • INACTIVE INGREDIENT

    Purified Water, Propanediol, Pentylene Glycol, Caprylic/Capric Triglyceride, Rosehip Fruit Oil, Niacinamide, Black Rice Bran Extract, Butylene Glycol, rh-Polypeptide-1, rh-Oligopeptide-1, rh-Oligopeptide-2, rh-Polypeptide-62, rh-Polypeptide-3, Ceramide NP, Panthenol, Tocopheryl Acetate, Nelumbium Speciosum Flower Extract, Hydrolyzed Hyaluronic Acid, Pseudoalteromonas Fermented Extract, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Cetearyl Olivate, Sorbitan Olivate, Hydrogenated Lecithin, Adenosine, Sodium Hyaluronate, Caprylyl Glycol, 1,2-Hexanediol

  • PURPOSE

    Skin Protectact

  • WARNINGS

    Precautions of Use
    1) If rash, redness, swelling, itching or other adverse reactions occur as a result of exposure to sunlight during or after use, consult a doctor / specialist.
    2) Refrain from using on wound sites.

  • KEEP OUT OF REACH OF CHILDREN

  • INDICATIONS & USAGE

    Apply the cream on the skin and spread evenly.

  • DOSAGE & ADMINISTRATION

    Apply the cream on the skin and spread evenly.

  • PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

    image description

  • INGREDIENTS AND APPEARANCE
    RAYDERM RE-GENERATING SERUM 
    glycerin serum lotion
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72543-003
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    glycerin (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) glycerin1.45 g  in 15 mL
    Inactive Ingredients
    Ingredient NameStrength
    water (UNII: 059QF0KO0R)  
    PROPANEDIOL (UNII: 5965N8W85T)  
    GLYCERETH-26 CAPRYLATE (UNII: EU2TQ69WRV)  
    1,2-HEXANEDIOL (UNII: TR046Y3K1G)  
    NIACINAMIDE (UNII: 25X51I8RD4)  
    C14-22 ALCOHOLS (UNII: B1K89384RJ)  
    PANTHENOL (UNII: WV9CM0O67Z)  
    TREHALOSE (UNII: B8WCK70T7I)  
    C12-20 ALKYL GLUCOSIDE (UNII: K67N5Z1RUA)  
    TROMETHAMINE (UNII: 023C2WHX2V)  
    CERAMIDE NP (UNII: 4370DF050B)  
    BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
    ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
    NELUMBO NUCIFERA FLOWER (UNII: 61W322NLDV)  
    ADENOSINE (UNII: K72T3FS567)  
    CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:72543-003-0115 mL in 1 PACKAGE; Type 0: Not a Combination Product10/11/2018
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other10/11/2018
    Labeler - VORY MEDICAL. Inc (694721104)
    Registrant - VORY MEDICAL. Inc (694721104)
    Establishment
    NameAddressID/FEIBusiness Operations
    VORY MEDICAL. Inc694721104manufacture(72543-003)

Related Drugs